Public Health Approaches to

st
Addressing the 21 Century
Opioid Epidemic
Jay C. Butler, MD, CPE
Chief Medical Officer,
Alaska Department of Health and Social Services
Director, Division of Public Health
Alaska News Dispatch, Aug 26, 2016
Prescription Opioid Sales and OD Deaths,
US, 1999-2013
 Medical Fallacies Driving the Increased
Prescribing of Opioids
Pain can be objectively measured
Tolerance is just under-dosing
Pseudoaddiction: persons who display drug-
seeking behavior are simply in pain and need
more opioids
If your medicine makes you feel better, then your
diagnosis must be whatever the medicine was meant to
treat Ann Lembke, MD, in Drug Dealer, MD
When used in treatment of pain, very little risk
of subsequent misuse or addiction
History of Opium Derivatives, Opioids, and
Pain Management

Porter J, Jick H. N Engl J Med 1980; 302:123

History of Opium Derivatives, Opioids, and
Pain Management

Porter J, Jick H. N Engl J Med 1980; 302:123

 * *
* Morphine Milligram Equivalents
Guy GP, et al. MMWR 2017; 66(26):697-704
 Opioid Prescribing Rates by County Vary
By Up to Six-Fold

Guy GP, et al. MMWR 2017; 66(26):697-704

 Opioid Overdose Deaths, US, 2000-2015

Frank RG, Pollack HA. N Engl J Med 2017; 376:605-7

Counterfeit 30mg generic oxycodone Counterfeit Norco (hydrocodone and
containing fentanyl, Tennessee acetaminophen) containing primarily
fentanyl and promethazine, California

Counterfeit Percocet (oxycodone and acetaminophen) containing

cyclopropyl fentanyl and U-47700, Georgia
 2017 Challenge:
Public Health Approaches to Preventing
Substance Misuse and Addictions

15
Conceptual Framework
Public Health Approaches to Preventing Opioid Misuse and Addiction
Public Health
3 Prevention Practice Paradigms
Prevent life-threatening Naloxone
adverse outcomes Acute health event
Syringe/Needle control and prevention
Exchange

2 Prevention Screening and Treatment

Diagnose and treat addictions Remove Stigma Chronic disease screening
and substance use disorders Understand Addiction as a Chronic and management
Condition of the Brain

1 Prevention Withdrawal Management and MAT

Reduce the need to Effective PDMPs and Use of Data
self-medicate Environmental
Rational Pain Management Judicious Prescribing controls and
Control access to
addictive substances Drug Take-Back Integrated Behavioral Health Services social
Promote protective Prevent and Mitigate ACEs Adolescent Risk Reduction determinants
factors Personal and Community Resiliency

Foundation: Effective, Evidence-Based Education and Communication

Cross-Sectoral Collaboration is Key
Public Health Attorneys General Justice and Medical Boards
Agencies Offices Corrections

Healthcare Providers Hospitals and Clinics Community Coalitions Businesses and Labor

Media Emergency Medical Social Services Faith Communities

Services Agencies

Pharmaceutical Educators Third-Party Payers Others

Industry
 Governor

Alaska Opioid Opioid Response Multi-Agency Coordination

(MAC) Group: Possible Participants
Opioid Response
Incident Commander
Alaska Criminal Information
& Analysis Center

Response Governors
Office
DHSS DOC

Opioid Response

Incident
DCCED DEED DPS Deputy IC

DOL Local/Tribal Federal Public Information

Command System Entities Entities Officer

Liaison Officer

State Disaster Declaration

February 14, 2017
Administrative Order 287 Opioid Response
Operations Section
Opioid Response
Logistics Section
Opioid Response
Planning Section
Opioid Response
Finance Section

Multi-agency approach
Local, Tribal, State, Federal, Law Enforcement Procurement and
Transportation
Situation Unit SOA Grants

and Non-Governmental
Agencies CommunityBased Documentation Unit

Prevention
Multi-Agency Coordination
(MAC) Group Provider and Public Federal Grant
Education Tracking
Incident Command System
Alaska Criminal Information Opioid Use Disorder
Treatment Opioid Response Joint
and Analysis Center Information Team

Governors Office / DHSS /

Joint Information System Criminal Justice
Populations
DPS / DOC / DCCED / DEED /
DOL

Prescription Drug
Monitoring Prog

School Based
Prevention/Education
What Can We Do?
Increase access to naloxone
Provide public and professional education on
administering naloxone and managing overdose
Eliminate liability and financial barriers
Authorize standing orders, third-party prescribing, and
pharmacist independent dispensing

Support clean needle use

End drug paraphernalia laws that restrict access
Support syringe and needle sales and exchange programs

Reduce impaired driving

Support widespread and sustained use of ignition interlocks
Implement sobriety checkpoints

19
21
22
23
What Can We Do?
Reframe addictions
Promote a science-based understanding of
addictions
Increase awareness of addictions as chronic
health conditions
Increase screening and diagnosis
Incorporate Screening, Brief Intervention and Referral to Treatment (SBIRT) into
healthcare and social services
Improve access to withdrawal symptom management and support
for recovery
Remove barriers to access to therapy for withdrawal symptom management
and maintenance of recovery
Train prescribers and dispensers on identifying and managing addictions
Increase facilities and providers
Encourage third-party payer coverage

24
25
What Can We Do?
Promote healthy families and increase resiliency
Promote maternal and early childhood health
programs
Prioritize pregnant women for screening and
access to treatment
Utilize tools outlined in CDCs 2016 technical
package, Preventing Child Abuse and Neglect
Reduce the supply of opioids in communities
Develop and utilize user-friendly, robust PDMPs
Support criminal justice reforms that focus on dealers rather than users
Support safer pain management and judicious prescribing
Expand public and professional education, including evidence-based pain
management guidelines and non-opioid pain management strategies
Develop and promote safe medication storage practices and drug return
programs

28
29
30
31
What Will Success Look Like?
Near horizon (next 3 years)
Reduced deaths from drug overdose
Declines in motor vehicle crashes from impaired driving
Fewer self-injection related HIV and HCV infections
Less unintentional injuries and self-harm related to drugs and alcohol
Further horizons
Lower rates of drug misuse and addiction, including underage use
Reduced drug- and alcohol-related incarceration and re-incarceration of
persons with addictions
Lower rates of crime and referrals to child protective services
Less interpersonal violence, self-harm, and child neglect
Prevention of excessive prescriptions for controlled substances while
improving wellness and function

32
Scope of Substance Misuse and Addictions

Legal
Substances Alcohol, Marijuana

Illicit
Substances Heroin, Methamphetamines, Synthetic Cannabinoids, Cathinones

Therapeutic
Substances and
Opioids, Amphetamines, Benzodiazepines
Prescription Drugs

Emerging
Technologies Powdered Alcohol, Vaping Devices, Designer Psychoactives